CX-6258 hydrochloride hydrate
|
(3E)-5-氯-3-[[5-[3-[(六氫-4-甲基-1H-1,4-二氮雜卓-1-基)羰基]苯基]-2-呋喃基]亞甲基]-1,3-二氫-2H-吲哚-2-酮鹽酸鹽水合物
|
1353858-99-7
|
CX-6258 hydrochloride
|
CX-6258HCL
|
1353859-00-3
|
Zorifertinib
|
AZD3759
|
1626387-80-1
|
Lifirafenib
|
LIFIRAFENIB
|
1446090-79-4
|
CHZ868
|
1895895-38-1
|
1895895-38-1
|
Lavendustin A
|
薰草菌素
|
125697-92-9
|
PIM-447 dihydrochloride
|
PIM447 DIHYDROCHLORIDE
|
1820565-69-2
|
JAK3-IN-1
|
1805787-93-2
|
1805787-93-2
|
Ilginatinib maleate
|
1354799-87-3
|
1354799-87-3
|
Ilginatinib
|
1239358-86-1
|
1239358-86-1
|
Ilginatinib hydrochloride
|
1239358-85-0
|
1239358-85-0
|
Naquotinib mesylate
|
ASP-8273
|
1448237-05-5
|
EGFR-IN-3
|
RX-518
|
1660963-42-7
|
Avitinib maleate
|
N-(3-((2-((3-氟-4-(4-甲基哌嗪-1-基)苯基)氨基)-7H-吡咯并[2,3-D]嘧啶-4-基)氧基)苯基)丙烯酰胺酸鹽
|
1557268-88-8
|
NRC-2694
|
936446-61-6
|
936446-61-6
|
PF-06459988
|
化合物PF-06459988
|
1428774-45-1
|
Neratinib
|
來那替尼
|
698387-09-6
|
Tarlox-TKI
|
Kinase inhibitor-1
|
2135696-72-7
|
Ruxolitinib (S enantiomer)
|
S-魯索替尼
|
941685-37-6
|
Lestaurtinib
|
來他替尼
|
111358-88-4
|
Gefitinib hydrochloride
|
4-(3-氯-4-氟苯基氨基)-7-甲氧基-6-[3-(4-嗎啉基)丙氧基]喹唑啉鹽酸鹽
|
184475-55-6
|
Gefitinib D8
|
吉非替尼雜質(zhì)-D8
|
857091-32-8
|
Lapatinib ditosylate
|
二對甲苯磺酸拉帕替尼
|
388082-77-7
|
Mutated EGFR-IN-1
|
AZD9291中間體1
|
1421372-66-8
|
Osimertinib dimesylate
|
OSIMERTINIB DIMESYLATE
|
2070014-82-1
|
Niclosamide olamine
|
氯硝柳胺乙醇胺鹽
|
1420-04-8
|
Khellin
|
凱林
|
82-02-0
|
Mutant EGFR inhibitor
|
N-[5-[[5-氯-4-(1H-吲哚-3-基)-2-嘧啶基]氨基]-2-[[2-(二甲基氨基)乙基]甲基氨基]-4-甲氧基苯基]-2-丙烯酰胺
|
1421373-62-7
|
CP-724714
|
2-甲氧基-N-[(2E)-3-[4-[[3-甲基-4-[(6-甲基-3-吡啶基)氧基]苯基]氨基]-6-喹唑啉基]-2-丙烯-1-基]乙酰胺
|
383432-38-0
|
NVP-BSK805 dihydrochloride
|
1942919-79-0
|
1942919-79-0
|
Homoharringtonine
|
高三尖杉酯堿
|
26833-87-4
|
NSC 74859
|
S3I-201
|
501919-59-1
|
Icotinib Hydrochloride
|
凱美納
|
1204313-51-8
|
Baricitinib phosphate
|
巴瑞克替尼磷酸鹽
|
1187595-84-1
|
RGB-286638
|
N-[1,4-二氫-3-[4-[[4-(2-甲氧基乙基)-1-哌嗪基]甲基]苯基]-4-氧代茚并[1,2-C]吡唑-5-基]-N'-4-嗎啉基脲鹽酸鹽
|
784210-87-3
|
AZD1208
|
AZD1208
|
1204144-28-4
|
Tyrphostin 23
|
酪氨酸磷酸化抑制劑23
|
118409-57-7
|
Rociletinib hydrobromide
|
CO-1686 氫溴酸鹽
|
1446700-26-0
|
Osimertinib mesylate
|
AZD9291(甲磺酸鹽)
|
1421373-66-1
|
AG-825
|
酪氨酸磷酸化抑制劑 AG 825
|
149092-50-2
|
Cerdulatinib hydrochloride
|
CERDULATINIB 鹽酸鹽
|
1369761-01-2
|
SH-4-54
|
SH-4-54
|
1456632-40-8
|
GDC-0339
|
1428569-85-0
|
1428569-85-0
|
Itacitinib adipate
|
1334302-63-4
|
1334302-63-4
|
Tarloxotinib bromide
|
1636180-98-7
|
1636180-98-7
|
Ochromycinone
|
抑胃酶氨酰-21
|
111540-00-2
|
TCS PIM-1 1
|
TCS PIM-1 1
|
491871-58-0
|
CX-6258
|
(Z)-5-CHLORO-3-((5-(3-(4-METHYL-1,4-DIAZEPANE-1-CARBONYL)PHENYL)FURAN-2-YL)METHYLENE)INDOLIN-2-ONE.HCL
|
1202916-90-2
|
Napabucasin
|
2-乙?;秽?1,4-萘醌
|
83280-65-3
|
GLPG0634 analog
|
GLPG0634
|
1206101-20-3
|
Alantolactone
|
土木香內(nèi)酯
|
546-43-0
|
Cryptotanshinone
|
隱丹參酮
|
35825-57-1
|
Diosgenin
|
薯蕷皂素
|
512-04-9
|
Artesunate
|
青蒿琥酯
|
88495-63-0
|
Cyasterone
|
杯莧甾酮
|
17086-76-9
|
Nitidine chloride
|
氯化兩面針堿
|
13063-04-2
|
Curculigoside
|
仙茅苷
|
85643-19-2
|
Scutellarin
|
野黃芩苷
|
27740-01-8
|
Corylifol A
|
3-[3-[(2E)-3,7-二甲基-2,6-辛二烯-1-基]-4-羥基苯基]-7-羥基-4H-1-苯并吡喃-4-酮
|
775351-88-7
|
Tephrosin
|
羥基魚藤素
|
76-80-2
|
Brevilin A
|
短葉老鸛草素A
|
16503-32-5
|
β-Hydroxyisovalerylshikonin
|
BETA-羥基異戊酰紫草素
|
7415-78-3
|
Astragaloside VI
|
黃芪皂苷VI
|
84687-45-6
|
Reticuline
|
牛心果鹼
|
485-19-8
|
Triacetylresveratrol
|
乙?;邹继J醇
|
42206-94-0
|
Hispidulin
|
高車前素
|
1447-88-7
|
Mogrol
|
羅漢果醇
|
88930-15-8
|
Sulforaphene
|
萊菔素
|
592-95-0
|
Ginsenoside Rk1
|
人參皂苷RK2
|
494753-69-4
|
Arnicolide D
|
山金車內(nèi)酯D
|
34532-68-8
|
Garcinone C
|
GARCINONE C
|
76996-27-5
|
Coumermycin A1
|
香豆霉素
|
4434-05-3
|
EGFR Protein Tyrosine Kinase Substrate
|
|
945830-38-6
|
Cetuximab
|
西妥昔單抗
|
205923-56-4
|
Trastuzumab
|
曲妥珠單抗
|
180288-69-1
|
Pertuzumab
|
帕妥珠單抗
|
380610-27-5
|
ZD-4190
|
413599-62-9
|
413599-62-9
|
GNE-495
|
GNE-495
|
1449277-10-4
|
TBHQ
|
特丁基對苯二酚
|
1948-33-0
|
M2698
|
M2698
|
1379545-95-5
|
RAF709
|
化合物RAF709
|
1628838-42-5
|
(E)-Necrosulfonamide
|
N-[4-[[(3-甲氧基吡嗪基)氨基]磺?;鵠苯基]-3-(5-硝基-2-噻吩基)-2-丙烯酰胺
|
1360614-48-7
|
APS-2-79
|
2002381-25-9
|
2002381-25-9
|
EMI56
|
EMI56
|
2414374-41-5
|
BD750
|
2-(2-Benzothiazolyl)-4,5,6,7-tetrahydro-2H-indazol-3-ol
|
892686-59-8
|
SGI-1776
|
SGI-1776
|
1025065-69-3
|
Tesevatinib
|
XL-647
|
781613-23-8
|
Afatinib impurity 11
|
無中文名稱
|
1402086-20-7
|
AG-1478
|
AG1478
|
153436-53-4
|
Oclacitinib maleate
|
PF-03394197
|
1640292-55-2
|
(Rac)-JBJ-04-125-02
|
CPD3616
|
2140807-05-0
|
Mobocertinib
|
莫博替尼
|
1847461-43-1
|
Mobocertinib succinate
|
琥珀酸莫博替尼
|
2389149-74-8
|
CK2/ERK8-IN-1
|
CK2/ERK8-IN-1
|
1085822-09-8
|
Chrysophanol
|
大黃酚
|
481-74-3
|
JCN037
|
JCN037
|
2305154-31-6
|
JAK2-IN-6
|
化合物JAK2-IN-6
|
353512-04-6
|
NCB-0846
|
NCB-0846
|
1792999-26-8
|
GS-444217
|
ASK1-IN-1
|
1262041-49-5
|
LY3214996
|
LY3214996
|
1951483-29-6
|